Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Schreiber, M. Busch, S. Kleinman, J. Korelitz (1996)
The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.The New England journal of medicine, 334 26
C. Valeri, G. Ragno, H. Macgregor, L. Pivacek (1997)
The Effect of Disinfection on Viability and Function of Baboon Red Blood CellsPhotochemistry and Photobiology, 65
J. AuBuchon, C. Pickard, L. Herschel, J. Roger, J. Tracy, A. Purmal, J. Chapman, S. Ackerman, Kathleen J. Beach (2002)
Production of pathogen‐inactivated RBC concentrates using PEN110 chemistry: a Phase I clinical studyTransfusion, 42
G. Schreiber, M. Busch, S. Kleinman, J. Korelitz (1996)
The Risk of Transfusion-Transmitted Viral InfectionsThe New England Journal of Medicine, 334
Jann-Tay Wang, C. Lee, J. Kao, J. Sheu, T. Wang, Ding‐Shinn Chen (2000)
Incidence and clinical presentation of posttransfusion TT virus infection in prospectively followed transfusion recipients: emphasis on its relevance to hepatitisTransfusion, 40
Wagner Wagner, Friedman Friedman, Dodd Dodd (1994)
Transfusion‐associated bacterial sepsis.Clin Microbiol Rev, 7
E. Budowsky, M. Zalesskaya, N. Nepomnyashchaya, R. Kostyanovsky (1996)
Principles of selective inactivation of the viral genome : Dependence of the rate of viral RNA modification on the number of protonizable groups in ethyleneimine oligomers, 5
Valeri Valeri, Pivacek Pivacek, Cassidy Cassidy, Ragno Ragno (2000)
The survival, function, and hemolysis of human RBCs stored at 4°C in additive solution (AS‐1, AS‐3, or AS‐5) for 42 days and then biochemically modified, frozen, thawed, washed, and stored at 4°C in sodium chloride and glucose solution for 24 hours.Transfusion, 40
J. Aubin, C. Defer, M. Vidaud, M. Montreuil, B. Flan (2000)
Large–Scale Screening for Human Parvovirus B19 DNA by PCR: Application to the Quality Control of Plasma for FractionationVox Sanguinis, 78
T. O'Connor, S. Boiteux, J. Laval (1988)
Ring-opened 7-methylguanine residues in DNA are a block to in vitro DNA synthesisNucleic acids research, 16 13
(1931)
Contributions to the collective treatment of a pharmacological series of experiments
M. Busch, S. Kleinman, B. Jackson, S. Stramer, I. Hewlett, S. Preston (2000)
Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors.Transfusion, 40 2
J. Allain (1998)
Emerging Viruses in Blood TransfusionVox Sanguinis, 74
A. Handa, B. Dickstein, N. Young, K. Brown (2000)
Prevalence of the newly described human circovirus, TTV, in United States blood donorsTransfusion, 40
L. Goodnough, M. Brecher, M. Kanter, J. AuBuchon (1999)
Transfusion medicine. First of two parts--blood transfusion.The New England journal of medicine, 340 6
K. Hemminki (1984)
Reactions of ethyleneimine with guanosine and deoxyguanosine.Chemico-biological interactions, 48 3
(2001)
Closing the windows on viral transmission by blood transfusion
McClurkin McClurkin, Coria Coria (1978)
Selected isolates of bovine viral diarrhea (BVD) virus propagated on bovine turbinate cells: virus titer and soluble antigen production as factors in immunogenicity of killed BVD virus.Arch Virol, 58
BACKGROUND: A pathogen‐inactivation process for RBC concentrates is being developed by using PEN110 chemistry (INACTINE, V.I. Technologies). The objective of this study was to characterize the quality of RBCs prepared by using the PEN110 process and to measure the virucidal effect achieved against two viruses. STUDY DESIGN AND METHODS: Virology and RBC studies were conducted with standard RBC units treated with 0.1‐percent (vol/vol) PEN110 at 22°C for 6 hours. The quality of PEN110‐treated human RBCs was assessed with biochemical and phenotypic variables. The in vivo viability of PEN110‐treated RBCs in baboons was studied with the double‐label 51Cr/125I method. RESULTS: Decreases in infectious titer by inactivation of greater than a 5 log 50‐percent tissue culture infectious doses per mL of bovine viral diarrhea virus (an enveloped RNA virus) and porcine parvovirus (a nonenveloped DNA virus) was observed. RBC hemolysis was less than 1 percent after 42 days of storage, and no changes in RBC antigens were observed. The in vivo viability of PEN110‐treated baboon RBCs was unchanged from control. CONCLUSION: The preparation of RBCs by using the PEN110 process achieved a significant viral reduction of two diverse viruses without causing adverse effects to the RBCs. The process appears to be a promising approach, thus justifying further study.
Transfusion – Wiley
Published: Feb 1, 2002
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.